S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
S&P 500   3,870.29 (-0.81%)
DOW   31,391.52 (-0.46%)
QQQ   318.40 (-1.60%)
AAPL   125.12 (-2.09%)
MSFT   233.87 (-1.30%)
FB   259.00 (-2.23%)
GOOGL   2,064.48 (-0.25%)
TSLA   686.44 (-4.45%)
AMZN   3,094.53 (-1.64%)
NVDA   536.25 (-3.15%)
BABA   234.42 (-3.01%)
CGC   35.25 (+1.50%)
GE   12.98 (-0.99%)
MU   91.09 (-3.87%)
NIO   43.29 (-13.00%)
AMD   84.13 (-2.62%)
T   28.22 (+0.46%)
F   12.55 (+4.76%)
ACB   11.03 (-0.09%)
DIS   193.94 (-0.53%)
BA   223.14 (-0.56%)
NFLX   547.82 (-0.51%)
BAC   35.53 (-0.73%)
Log in
NASDAQ:CBPO

China Biologic Products Stock Forecast, Price & News

$117.85
-0.35 (-0.30 %)
(As of 03/2/2021 04:30 PM ET)
Add
Compare
Today's Range
$117.52
Now: $117.85
$118.44
50-Day Range
$117.84
MA: $118.67
$119.88
52-Week Range
$97.91
Now: $117.85
$120.01
Volume124,978 shs
Average Volume179,507 shs
Market Capitalization$4.64 billion
P/E Ratio32.92
Dividend YieldN/A
Beta0.47
China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. The company was founded in 2002 and is headquartered in Beijing, China.
China Biologic Products logo

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CBPO
CUSIPN/A
Phone861065983111
Employees2,269
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$503.70 million
Cash Flow$4.92 per share
Book Value$45.09 per share

Profitability

Net Income$138.81 million

Miscellaneous

Market Cap$4.64 billion
Next Earnings Date3/11/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

0.82 out of 5 stars

Medical Sector

1141st out of 1,968 stocks

Biological Products, Except Diagnostic Industry

140th out of 177 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$117.85
-0.35 (-0.30 %)
(As of 03/2/2021 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CBPO News and Ratings via Email

Sign-up to receive the latest news and ratings for CBPO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











China Biologic Products (NASDAQ:CBPO) Frequently Asked Questions

What stocks does MarketBeat like better than China Biologic Products?

Wall Street analysts have given China Biologic Products a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but China Biologic Products wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting China Biologic Products?

China Biologic Products saw a increase in short interest in February. As of February 12th, there was short interest totaling 979,000 shares, an increase of 104.3% from the January 28th total of 479,200 shares. Based on an average daily volume of 188,400 shares, the short-interest ratio is presently 5.2 days. Currently, 5.6% of the shares of the stock are short sold.
View China Biologic Products' Short Interest
.

When is China Biologic Products' next earnings date?

China Biologic Products is scheduled to release its next quarterly earnings announcement on Thursday, March 11th 2021.
View our earnings forecast for China Biologic Products
.

How were China Biologic Products' earnings last quarter?

China Biologic Products Holdings, Inc. (NASDAQ:CBPO) announced its quarterly earnings data on Monday, November, 23rd. The biopharmaceutical company reported $1.39 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.28 by $0.11. The biopharmaceutical company earned $138.54 million during the quarter. China Biologic Products had a trailing twelve-month return on equity of 8.32% and a net margin of 27.43%. During the same quarter last year, the firm earned $1.40 EPS.
View China Biologic Products' earnings history
.

How has China Biologic Products' stock price been impacted by Coronavirus (COVID-19)?

China Biologic Products' stock was trading at $115.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CBPO shares have increased by 1.7% and is now trading at $117.85.
View which stocks have been most impacted by COVID-19
.

Who are China Biologic Products' key executives?

China Biologic Products' management team includes the following people:
  • Joseph Chow, Chairman & Chief Executive Officer
  • Ming Yang, Chief Financial Officer
  • Ming Yin, Senior Vice President

Who are some of China Biologic Products' key competitors?

What other stocks do shareholders of China Biologic Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Biologic Products investors own include Lexicon Pharmaceuticals (LXRX), NVIDIA (NVDA), Gilead Sciences (GILD), Sarepta Therapeutics (SRPT), Micron Technology (MU), Pfizer (PFE), AbbVie (ABBV), Alibaba Group (BABA), ACADIA Pharmaceuticals (ACAD) and Amgen (AMGN).

What is China Biologic Products' stock symbol?

China Biologic Products trades on the NASDAQ under the ticker symbol "CBPO."

Who are China Biologic Products' major shareholders?

China Biologic Products' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (1.59%), Alpine Associates Management Inc. (1.36%), BlackRock Inc. (1.07%), Hsbc Holdings PLC (0.98%), Athos Capital Ltd (0.92%) and Norges Bank (0.79%).
View institutional ownership trends for China Biologic Products
.

Which major investors are selling China Biologic Products stock?

CBPO stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Canada Pension Plan Investment Board, BlackRock Inc., Barclays PLC, Bank of New York Mellon Corp, Northern Trust Corp, California Public Employees Retirement System, and ProShare Advisors LLC.
View insider buying and selling activity for China Biologic Products
or view top insider-selling stocks.

Which major investors are buying China Biologic Products stock?

CBPO stock was purchased by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., Norges Bank, Hsbc Holdings PLC, Credit Suisse AG, Athos Capital Ltd, Citigroup Inc., Walleye Capital LLC, and ExodusPoint Capital Management LP.
View insider buying and selling activity for China Biologic Products
or or view top insider-buying stocks.

How do I buy shares of China Biologic Products?

Shares of CBPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is China Biologic Products' stock price today?

One share of CBPO stock can currently be purchased for approximately $117.85.

How much money does China Biologic Products make?

China Biologic Products has a market capitalization of $4.64 billion and generates $503.70 million in revenue each year. The biopharmaceutical company earns $138.81 million in net income (profit) each year or $4.28 on an earnings per share basis.

How many employees does China Biologic Products have?

China Biologic Products employs 2,269 workers across the globe.

What is China Biologic Products' official website?

The official website for China Biologic Products is www.chinabiologic.com.

Where are China Biologic Products' headquarters?

China Biologic Products is headquartered at 18TH FL JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD CHAOYANG DISTRICT, BEIJING F4, 100125.

How can I contact China Biologic Products?

China Biologic Products' mailing address is 18TH FL JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD CHAOYANG DISTRICT, BEIJING F4, 100125. The biopharmaceutical company can be reached via phone at 861065983111 or via email at [email protected]


This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.